Diquafosol eye drops for moderate-to-severe eye allergy
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests a new eye drop called diquafosol for people with a severe, active eye allergy called vernal keratoconjunctivitis. It aims to see if the drops can calm the allergy and help heal the surface of the eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 6 years old or older.
- You have been diagnosed with vernal keratoconjunctivitis (a severe eye allergy).
- Your eye allergy is currently moderate to severe.
- You have damage to the surface of your eye (cornea) from the allergy.
- You have had at least one flare-up of this eye allergy in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tacrolimus eye drops can safely treat severe eye allergies (vernal keratoconjunctivitis) in children ages 5 to 15. It aims to reduce symptoms like itching, redness, and discomfort.
This trial tests whether a special eye drop (3% Diquafosol) can help with dry eye symptoms caused by wearing overnight contact lenses called orthokeratology (OK) lenses. It will look at how the drops affect your tears and your vision-related quality of life.
This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.
This trial tests whether a 3% diquafosol eye drop or a 0.1% hyaluronic acid eye drop works better for dry eye symptoms that started after LASIK surgery.
This study tests a new medication called DFL24498 for people with atopic keratoconjunctivitis (AKC), a severe allergic eye condition. The goal is to see if it reduces itching, discomfort, and eye redness safely.
This study tests two eye drops—3% Diquafosol and 0.1% Hyaluronic Acid—after a type of laser eye surgery (Trans-PRK) to see which one works better for dry-eye symptoms.
Hear when a new Vernal Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.